Nabil Tabish: TEG Reveals the True Effect of Heparin During ECMO
Nabil Tabish, Regional Medical Director at Kaiser Permanente, shared a post on LinkedIn:
”This infographic visually tells the story of a patient on ECMO; we discussed, focusing on the critical difference between measuring Unfractionated heparin’s chemical concentration versus its actual, functional effect. It contrasts two very different diagnostic views of the same patient:
The Misleading Standard Labs: On one side, the plasma-based labs (the anti-Xa level of 0.38 IU/mL and PTT of 47 seconds) falsely suggested the patient was only mildly anticoagulated. These isolated tests can be highly misleading in complex scenarios like ECMO where factors like Antithrombin III are depleted.
The Accurate TEG 6s Assessment: On the other side, the design highlights the TEG 6s whole-blood functional assessment. It illustrates the stark contrast between the patient’s severely prolonged CK (Citrated Kaolin) R-time of greater than 17 minutes and their completely normal CKH (Citrated Kaolin with Heparinase) R–time of 6.9 minutes.
By visually showing how neutralizing the heparin in the CKH channel instantly corrects the delayed clotting time, there is mechanical proof that the heparin profoundly anticoagulanting the patient.
Ultimately, the piece visually reinforces the manufacturer’s guidance that diagnostic results should always be evaluated and functional assays play a superior role in complex clinical patients with a refined balance between thrombosis and anticoagulation.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026